The Medicines Company (MDCO)

Magnet0 (82.79) Submitted: 5/13/2009 5:50:39 PM : Start Price: $7.22 MDCO Score: -16.89

quality company, took a fatty nose dive

TSIF (98.76) Submitted: 5/12/2009 2:46:39 PM : Start Price: $11.14 MDCO Score: -52.11

The Medicine Company, winning name, great pitch, "cost effective acute care"!. How could it lose! Overall for a pharmaceutical company Medicines has a decent and increasing revenue stream from Angiomax and several other products. From the company profile Angiomax is " an intravenous direct thrombin inhibitor for use as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty". Wow, I don't know what it means, but it must be good! Yes, patents are short, which appears to be keeping the price down, but it has other drugs in the "blood arena" and we all need healthy blood! They will need to watch their backs, but no debt, cash flow, well respected products and a good distribution system and I'd rather have my money in a company like this than an auto parts or a bank, especially if I need to go to the hospital to have my thromin fixed.

zzlangerhans (99.57) Submitted: 2/20/2009 1:07:40 PM : Start Price: $12.61 MDCO Score: -84.78

It's not clear to me why Medicines has fallen so far despite a relatively stable financial picture. Angiomax revenues have been increasing and generics will not be available before 2010 at the earliest. That gives Medicines time to grow Cleviprex revenues and develop their pipeline. I'm not really a bull here but this company has the tools to survive and will likely be one to rebound in the short term when the market stabilizes, given no major negative catalysts.

escarzamd (< 20) Submitted: 5/31/2008 2:26:29 PM : Start Price: $18.25 MDCO Score: -38.58

Hearing good things from cardiologists about Angiomax. recent support from journals. Could be a combo w/BMY for cath patients. No debt on board, so if this drug hits.......the stock could go out of the yard.

popsstocs (< 20) Submitted: 9/8/2007 3:39:10 PM : Start Price: $16.47 MDCO Score: -31.42

I have made some good profits off this CO.I guess it makes all that money from selling all those expensive medications,but what ever,It does me good and I played it again,and its already on its way to do ole pops right again.

StocksdatROCK (37.69) Submitted: 9/4/2007 7:53:25 PM : Start Price: $16.81 MDCO Score: -31.48

Has the worlds favorite item and to many customers

almond9090 (< 20) Submitted: 8/17/2007 5:43:16 AM : Start Price: $16.50 MDCO Score: -32.06

Consistent steady growth with well-established product should slightly outperform the market.

aaroger (26.05) Submitted: 7/27/2007 10:45:14 AM : Start Price: $17.21 MDCO Score: -32.59

34

agard43 (< 20) Submitted: 3/22/2007 10:31:33 PM : Start Price: $25.17 MDCO Score: +49.90

TheStreet.com: "There still seems to be a lot of hope built into the stock price. As Morgan Stanley analyst Stephen Herr wrote this week, "if the patent life is not extended, this stock looks broadly overvalued."

naygoo (55.59) Submitted: 12/11/2006 1:50:32 PM : Start Price: $30.96 MDCO Score: +56.83

Shares of the Medicines Co. (NASDAQ:MDCO - News) fell 10 percent on Monday after the U.S. Congress failed to enact a bill that would have helped the company's bid to extend a patent on its flagship drug Angiomax, a blood thinner.